ICM
AEE icon

Invenomic Capital Management’s Ameren AEE Stock Holding History

Invenomic Capital Management’s Portfolio AEE Stock Details AEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-194,200
Closed -$14.4M – 162
2024
Q1 		$14.4M Sell
194,200
-9,534
-5% -$678K 0.76% 51
2023
Q4 		$14.7M Sell
203,734
-184,952
-48% -$14.1M 0.67% 52
2023
Q3 		$29.1M Buy
+388,686
New +$31.7M 1.22% 22
2020
Q3 		– Sell
-13,540
Closed -$953K – 143
2020
Q2 		$953K Hold
13,540
– – 0.71% 50
2020
Q1 		$986K Buy
+13,540
New +$1.07M 0.81% 45

Other funds holding AEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Invenomic Capital Management's AEE Position: Q2 2024 in Review

Invenomic Capital Management sold out of Ameren (AEE) in Q2 2024, closing a stake of 194,200 shares — an estimated $14.4M sold.

Invenomic Capital Management first reported a position in AEE in Q1 2020 and held it in 5 quarters. The position peaked at $29.1M in Q3 2023. 661 funds tracked by Wall St. Rank hold AEE as of Q2 2024.

  • Invenomic Capital Management reported no remaining Ameren position as of Q2 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 194,200 Ameren shares in Q2 2024, an estimated $14.4M.
  • Invenomic Capital Management first reported a position in Ameren in Q1 2020 and held it in 5 quarters.
  • Invenomic Capital Management's Ameren position peaked at $29.1M in Q3 2023.
  • 661 funds tracked by Wall St. Rank held Ameren as of Q2 2024.

Based on Invenomic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.